Z7- THCA 10.1%. THC 0.76%. CBDA 13.4%. CBD 0.24%. CBGA 0.37%. CBG 0.33%. CBC 0.32%. THCV 0.173%. LABEL TOTALS THC 9.5% CBD 12.0%.
The cannabinoid profile for Z7 shows it to be a solid choice for a wide variety of medical cannabis patients. Terpene analysis shows a strong myrcene dominance which can help decrease baseline anxiety and moderate those from THC. It can be sedating to some patients. New to cannabis patients or patients who have experienced some anxiety with THC will find the strain well tolerated as the high CBD and the THCV will moderate some of the psychoactive effects of THC. The CBG and CBC are both potent anti inflammatory drugs making this a good choice for patients with arthritis and for patients with neurodegenerative diseases such as Huntington’s disease, Parkinson’s disease, etc. Peripheral neuropathy, arthritis, many neuroinflammatory and fibromyalgia patients should consider this their first choice of the currently available strains.